Serum macrophage‐derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|137|4|826-836

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.4, 2015-08, pp. : 826-836

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content